Trials / Completed
CompletedNCT02867358
A Clinical Trial of KT07 Capsule in the U.S.A
A Multi-center, Randomized, Double-blind, and Placebo-controlled Phase II Clinical Study to Investigate the Safety and Efficacy of Two Doses of KT07 Compared to Placebo in Subjects With Acute Uncomplicated Influenza
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 391 (actual)
- Sponsor
- Yiling Pharmaceutical Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate clinical efficacy of KT07 capsule in alleviation of fever and other symptoms including nasal congestion, sore throat, cough, aches and pains, fatigue, headache, chills or sweats in subjects with acute uncomplicated influenza.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KT07 Capsule | |
| OTHER | Placebo |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2020-07-31
- Completion
- 2020-07-31
- First posted
- 2016-08-15
- Last updated
- 2020-08-31
Locations
81 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02867358. Inclusion in this directory is not an endorsement.